New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 2, 2014
06:02 EDTAVNRAvanir upgraded to Buy from Neutral at Mizuho
Mizuho upgraded Avanir Pharmaceuticals to Buy citing the Nuedexta patent case victory and the company's pipeline. The firm doubled its price target for shares to $10 from $5.
News For AVNR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AVNR

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use